Almuradova D.M., Ravshanova N.B., and Abdurakhimov A.I., “Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis”, ijmscr, vol. 6, no. 03, pp. 82–86, Mar. 2026.